Looking at how well drugs work in routine clinical practice, rather than only in experimental randomised controlled clinical trials (RCTs), is increasingly seen as essential for a proper assessment of both net benefit (health gain minus harm and value (net benefit minus net cost). Establishing...

Social health care systems around the world are inevitably confronted with the scarcity of resources and the resulting distributional challenges. Prioritization is applied in almost all countries, implicitly or explicitly, and shapes access to health services. We analyze and compare attitudes...

This paper investigates the impact of policies and institutions on health expenditures for a large panel of OECD countries for the period 2000-10. We use a set of 20 policy and institutional indicators developed by the OECD characterising the main supply-side, demand-side, and public management,...

This paper investigates the impact of policies and institutions on health expenditures for a large panel of OECD countries for the period 2000-10. We use a set of 20 policy and institutional indicators developed by the OECD characterising the main supply-side, demand-side, and public management,...

This paper is part of a series that examines the way health services are funded and delivered in other nations. The nations profiled all aim to achieve the noble goal of Canada’s health care system: access to high quality care regardless of ability to pay. How they organize to achieve that...